Interestingly, immunohistochemical results showed that PKP2 expression was more robust in metastatic tumors than in non-metastatic tumors [64], suggesting that PKP2 plays a potential oncogenic role in the development of oral cancer. The gene discussed is PKP2; the disease is metastatic neoplasm.